ERBB2 and neoplasm: Additionally, a strong correlation was found between sHER2 levels quantified by ELISA and tumor HER2 status (r = 0.58, p < 0.0001), coupled with a moderate association between sHER2 levels measured by Dot blot assay and tumor HER2 status (r = 0.26, p < 0.1).